Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 60 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
SB Cardiology from Anderlecht, company number BE1029900666, closed financial year 2025 with a result of € -2,298 after tax. For that financial year SB Cardiology recorded a gross margin of € -2,288 and equity of € -298. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
€ -298
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2,298
Profit after tax over the fiscal year.
€ 1,060
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2,298.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to SB Cardiology?
What happened at SB Cardiology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 2,298. Source: NBB ↗
- New establishment in Anderlecht. KBO
- Sarah BENSLIMAN became a director. NBB
- Start of the company according to the CBE. KBO
A new publication or filing at SB Cardiology? We notify you, reason included.
Follow SB CardiologyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SB Cardiology is Sarah BENSLIMAN.
Directors
According to the 2025 annual accounts
Sarah BENSLIMAN
Director
since 2025
Establishments
Establishment units
Physical locations of this company
René Berrewaertslaan 20
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1029.900.666
- VAT number
- BE 1029.900.666
- Registered office
- René Berrewaertslaan 20, 1070 Anderlecht
- Names & denominations
- SB Cardiology
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 October 2025
- Peppol
- Active · Active since 7 Feb 2026